1-4 of 4
Alexander W. Hauswirth
Close
Sort by
Journal Articles

Phenotyping of Neoplastic (CD34 + /CD38 − /CD123 + ) Stem Cells in Myeloid Malignancies Reveals Expression of Multiple Molecular Targets.

Stefan Florian, MD, Karoline Sonneck, MD, Alexander W. Hauswirth, MD, Maria-Theresa Krauth, MD, Wolfgang R. Sperr, MD, Peter Valent, MD
Journal: Blood
Blood (2005) 106 (11): 1381.
https://doi.org/10.1182/blood.V106.11.1381.1381
Published: 2005
Journal Articles

The Target Receptor Siglec-3 (CD33) Is Expressed on AML Stem Cells in a Majority of All Patients with AML.

Alexander W. Hauswirth, MD, Stefan FLorian, MD, Maria-Theresa Krauth, MD, Gerit-Holger Schernthaner, MD, Edgar Selzer, MD, Volker Wacheck, MD, Dieter Printz, Gerhard Fritsch, MD, Karl Sotlar, MD, Wolfgang R. Sperr, MD, Peter Valent, MD
Journal: Blood
Blood (2005) 106 (11): 4324.
https://doi.org/10.1182/blood.V106.11.4324.4324
Published: 2005
Journal Articles

Clinical Course and Prognosis in Mast Cell Proliferative Disorders: A 17 Year Experience in a Single Center.

Wolfgang R. Sperr, MD, Friedrich Wimazal, MD, Alexandra Boehm, MD, Alexander W. Hauswirth, MD, Stefan Florian, Robert Fritsche-Polanz, MD, Manuela Foedinger, MD, Peter Valent, MD
Journal: Blood
Blood (2004) 104 (11): 4741.
https://doi.org/10.1182/blood.V104.11.4741.4741
Published: 2004
Journal Articles

C5a stimulates production of plasminogen activator inhibitor-1 in human mast cells and basophils

Johann Wojta, Christoph Kaun, Gerlinde Zorn, Minoo Ghannadan, Alexander W. Hauswirth, Wolfgang R. Sperr, Gerhard Fritsch, Dieter Printz, Bernd R. Binder, Georg Schatzl, Joerg Zwirner, Gerald Maurer, Kurt Huber, Peter Valent
Journal: Blood
Blood (2002) 100 (2): 517–523.
https://doi.org/10.1182/blood.V100.2.517
Published: 2002